Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-27 Sale | 2024-08-29 7:36 pm | SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 1,025,000 | $48.01 | $49,210,750 | 6,291,851 (Indirect) | View |
2024-04-29 Sale | 2024-05-01 1:10 pm | SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 1,101,242 | $46.95 | $51,701,551 | 7,316,851 (Indirect) | View |
2024-04-01 Sale | 2024-04-03 8:47 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 420,663 | $6.6487 | $2,796,859 | 268,573 (Indirect) | View |
2023-11-21 Sale | 2023-11-22 6:51 pm | Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Panda LLC Vivo Panda Fund L.P. 10% Owner | 3,400 | $0.9 | $3,060 | 1,559,948 (Indirect) | View |
2023-11-16 Sale | 2023-11-20 9:09 pm | Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Panda LLC Vivo Panda Fund L.P. 10% Owner | 77,843 | $0.92875 | $72,297 | 1,561,405 (Indirect) | View |
2023-08-09 Purchase | 2023-08-10 09:03 am | IO Biotech Inc. | IOBT | Vivo Capital IX LLC Vivo Capital Fund IX L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 3,157,894 | $1.9 | $5,999,999 | 9,331,333 (Indirect) | View |
2022-12-23 Purchase | 2022-12-23 5:48 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 758,620 | $7.25 | $5,499,995 | 6,657,992 (Indirect) | View |
2022-09-07 Purchase | 2022-09-08 8:00 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 600,000 | $3.6 | $2,160,000 | 5,899,372 (Indirect) | View |
2022-08-12 Purchase | 2022-08-16 8:44 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 2,624,239 | $2.6599 | $6,980,244 | 6,799,372 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-10-02 Exercise | 2023-10-04 4:30 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 5,215,000 | $2.5 | 8,418,093 (Indirect) | View |
2023-10-02 Exercise | 2023-10-04 4:30 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 5,215,000 | $0 | 8,418,093 (Indirect) | View |
2023-09-26 Exercise | 2023-09-28 5:00 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 3,203,093 | $0 | 3,203,093 (Indirect) | View |
2023-09-26 Exercise | 2023-09-28 5:00 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 3,203,093 | $1.75 | 3,203,093 (Indirect) | View |
Ownership | 2023-05-15 5:01 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 0 | $0 | 8,418,093 (Indirect) | View |
2022-07-01 Disposition | 2022-07-01 4:59 pm | 2019-11-13 2024-11-13 | Sierra Oncology Inc. | SRRA | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital IX LLC Vivo Capital Fund IX L.P. VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. Director 10% Owner | 1,855,873 | $0 | 0 (Indirect) | View |
2022-07-01 Disposition | 2022-07-01 4:59 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital IX LLC Vivo Capital Fund IX L.P. VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. Director 10% Owner | 3,329,512 | $55 | 0 (Indirect) | View |